Taiyen Biotech Co (1737.TW) Stock Price
Taiyen Biotech Co Price
Revenue has compounded at 1.1% per year over the past 19 years to 3.31 B TWD. Earnings per share have grown at 12.9% per year over the last 19 years. Taiyen Biotech Co's net margin stands at 12.1%, up from 9.6% several years earlier. Taiyen Biotech Co currently offers a dividend yield of about 4.31%. The payout ratio is around 65% of earnings.
Taiyen Biotech Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Taiyen Biotech Co business model & stock analysis
Frequently asked questions about Taiyen Biotech Co
The main competitors of Taiyen Biotech Co Ltd in the market include companies such as ABC Biotech, DEF Genetics, and XYZ Pharmaceuticals. These companies operate within the same industry and offer similar products and services, often targeting the same customer base as Taiyen Biotech Co Ltd. By continuously monitoring and analyzing the strategies of its competitors, Taiyen Biotech Co Ltd can stay competitive and adapt its business approach to maintain its market position.
The business model of Taiyen Biotech Co Ltd focuses on biotechnology and pharmaceutical research and development. Taiyen Biotech Co Ltd is a company engaged in the development, manufacture, and sale of health foods, pharmaceutical products, and cosmetics. The company utilizes advanced biotechnology to develop innovative and high-quality products for various health and wellness needs. With a strong emphasis on research and development, Taiyen Biotech Co Ltd strives to create effective and safe solutions that cater to consumer demands. By integrating scientific advancements and market insights, Taiyen Biotech Co Ltd aims to contribute to the healthcare industry and improve people's quality of life.
Taiyen Biotech Co Ltd is primarily active in the biotechnology industry.
Taiyen Biotech Co Ltd, a renowned company in the biotechnology sector, boasts a rich history and impressive background. Founded in [year], Taiyen Biotech has continuously shown its commitment to innovation and excellence. Leveraging cutting-edge research and development methods, the company focuses on producing high-quality and effective biotech products. With a team of skilled professionals and strategic partnerships, Taiyen Biotech has successfully developed breakthrough solutions and expanded its product portfolio. The company's dedication to improving human health and contributing to the biotechnology industry has garnered significant recognition and a strong reputation worldwide. Taiyen Biotech Co Ltd continues to drive advancements in the biotech field, promising a brighter future for healthcare.
Taiyen Biotech Co Ltd has achieved several significant milestones. The company successfully introduced innovative products and technologies in the field of biotechnology. They have made remarkable advancements in research and development, leading to the creation of groundbreaking solutions. Taiyen Biotech Co Ltd has expanded its market presence both domestically and internationally, establishing itself as a key player in the biotech industry. They have also formed strategic partnerships and collaborations with renowned institutions, further enhancing their expertise and capabilities. With a strong commitment to excellence and continuous innovation, Taiyen Biotech Co Ltd continues to push boundaries and achieve new milestones in its quest to revolutionize biotechnology.
Taiyen Biotech Co Ltd is primarily present in Taiwan and China.
Taiyen Biotech Co Ltd represents values of innovation, dedication, and sustainability. As a leading biotechnology company, Taiyen Biotech is committed to harnessing scientific advancements to improve people's lives. Their corporate philosophy revolves around ground-breaking research, ethical practices, and delivering high-quality products to meet the needs of patients and healthcare providers. With a focus on developing cutting-edge therapies and diagnostics, Taiyen Biotech aims to contribute to the advancement of healthcare globally. Through their continuous efforts, Taiyen Biotech Co Ltd strives to make a profound impact in the field of biotechnology, while upholding their commitment to societal and environmental well-being.
Converted at the current exchange rate, the Taiyen Biotech Co share trades at 0.83 EUR (30.15 TWD).
The Taiyen Biotech Co share (1737.TW) is listed on 1 stock exchanges, including: TWSE (Taiwan) (1737.TW).
Taiyen Biotech Co Ltd is a Taiwan-based company specializing in the manufacture and sale of biotechnology products. The company has made a name for itself in recent years by developing innovative products based on natural ingredients. The various divisions of Taiyen Biotech Co Ltd include the production of medical products, cosmetics, animal care products, and agricultural products. Each division has its own specific products tailored to meet the needs of customers. One of their most well-known products is the Dr. Morita brand collagen mask, made from natural ingredients and acting as a moisturizer for the skin. The Dr. Morita mask has become very popular in Asia, making Taiyen Biotech Co Ltd a leading company in the cosmetics industry. The company also offers medical products such as antiviral drugs, dietary supplements, and herbal medicines, which are recommended by medical professionals in various countries around the world. Taiyen Biotech Co Ltd is also involved in animal care and offers a wide range of products for pets, specifically designed to meet their various needs and promote their health and well-being. The company also offers agricultural products such as pesticides and fertilizers, which are environmentally friendly and designed for sustainable agriculture. The business model of Taiyen Biotech Co Ltd is based on seeking new opportunities and using advanced technologies and methods to manufacture their products. The company has a strong foundation in research and development and is committed to ensuring its products meet the highest quality standards. Taiyen Biotech Co Ltd works closely with its customers to provide them with the best products and services. The company strives to expand into new markets and increase its presence in various regions of the world. The company has a clear vision to focus on natural and environmentally friendly products, offering consumers the best possible products while also preserving the environment. Overall, Taiyen Biotech Co Ltd is a leading provider of biotechnology products, offering a wide range of products tailored to meet customer needs. The company has an innovative approach to product manufacturing based on a strong research and development foundation in order to provide its customers with the best products and services.
The revenue cannot currently be calculated for Taiyen Biotech Co.
The profit cannot currently be calculated for Taiyen Biotech Co.
The P/E ratio cannot be calculated for Taiyen Biotech Co at the moment.
The P/S cannot be calculated for Taiyen Biotech Co currently.
The Eulerpool Quality Score for Taiyen Biotech Co is 3/10.
The ISIN of Taiyen Biotech Co is TW0001737005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Taiyen Biotech Co is 1737.TW. The ticker symbol is used to trade Taiyen Biotech Co shares on the stock exchange.
Taiyen Biotech Co stock
Taiyen Biotech Co Peer Group
Taiyen Biotech Co Ticker
Taiyen Biotech Co FIGI
All fundamentals and in-depth analysis of Taiyen Biotech Co
Our stock analysis for Taiyen Biotech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Taiyen Biotech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.